ConductScience.org, home

Paper37589736

Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection?

Babaei F and 4 others. Naunyn Schmiedebergs Arch Pharmacol, 2024. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection? Papers, record 37589736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37589736

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Can nonsteroidal anti-inflammatory drugs (NSAIDs) be repurposed for fungal infection?
PubMed
Journal
Naunyn Schmiedebergs Arch Pharmacol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
3.42, provisional
iCite
Revised in PubMed
2026-10-31
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Babaei FFatemeh
2Mirzababaei MMohammadreza
3Tavakkoli AAlireza
4Nassiri-Asl MMarjanhttps://orcid.org/0000-0003-3701-0758
5Hosseinzadeh HHosseinhttps://orcid.org/0000-0002-3483-851X

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antifungal AgentsMajor topic
MycosesMajor topic
Humans
Dinoprostone
Anti-Inflammatory Agents, Non-Steroidal
Aspirin

References87

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119269752In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosum.Vet Microbiol2009https://conductscience.org/library/papers/19269752PubMed
231399349Insights on the anticandidal activity of non-antifungal drugs.J Mycol Med2019https://conductscience.org/library/papers/31399349PubMed
320364371Paracoccidioides brasiliensis uses endogenous and exogenous arachidonic acid for PGE x production.Mycopathologia2010https://conductscience.org/library/papers/20364371PubMed
431850393Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris.Curr Med Mycol2019https://conductscience.org/library/papers/31850393PubMed
526044360Involvement of electron and hydrogen transfers through redox metabolism on activity and toxicity of the nimesulide.J Mol Model2015https://conductscience.org/library/papers/26044360PubMed
624156913In vitro analysis of flufenamic acid activity against Candida albicans biofilms.Int J Antimicrob Agents2014https://conductscience.org/library/papers/24156913PubMed
727246782Repurposing of Aspirin and Ibuprofen as Candidate Anti-Cryptococcus Drugs.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27246782PubMed
836647379Candida albicans-enteric viral interactions-The prostaglandin E2 connection and host immune responses.iScience2023https://conductscience.org/library/papers/36647379PubMed
933203147Antifungal Drug Repurposing.Antibiotics (Basel)2020https://conductscience.org/library/papers/33203147PubMed
1025737988Ibuprofen-mediated reversal of fluconazole resistance in clinical isolates of Candida.J Clin Diagn Res2015https://conductscience.org/library/papers/25737988PubMed
1122510283Interaction of methylxanthines and gentamicin against Staphylococcus aureus and Pseudomonas aeruginosa: role of phosphodiesterase inhibition.Acta Microbiol Immunol Hung2012https://conductscience.org/library/papers/22510283PubMed
1229735520
Identification of Specific Components of the Eicosanoid Biosynthetic and Signaling Pathway Involved in Pathological Inflammation during Intra-abdominal Infection with Candida albicans and Staphylococcus aureus.
Infect Immun2018https://conductscience.org/library/papers/29735520PubMed
1335084852Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles.J Med Chem2022https://conductscience.org/library/papers/35084852PubMed
1420819061Saccharomyces cerevisiae β-carbonic anhydrase: inhibition and activation studies.Curr Pharm Des2010https://conductscience.org/library/papers/20819061PubMed
1528151949Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicans.PLoS One2017https://conductscience.org/library/papers/28151949PubMed
1630818309Therapeutic tools for oral candidiasis: Current and new antifungal drugs.Med Oral Patol Oral Cir Bucal2019https://conductscience.org/library/papers/30818309PubMed
1723545303Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity.Infect Immun2013https://conductscience.org/library/papers/23545303PubMed
1819416368Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.FEMS Yeast Res2009https://conductscience.org/library/papers/19416368PubMed
1934103949Cotreatment with Aspirin and Azole Drugs Increases Sensitivity of Candida albicans in vitro.Infect Drug Resist2021https://conductscience.org/library/papers/34103949PubMed
2029605543Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.J Mycol Med2018https://conductscience.org/library/papers/29605543PubMed

See all 87 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42622487Structural Modifications of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): New Horizons in Antimicrobial Drug Discovery.Arch Pharm (Weinheim)2026https://conductscience.org/library/papers/42622487PubMed
42406005Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.Ther Innov Regul Sci2026https://conductscience.org/library/papers/42406005PubMed
40426549Repurposing Mouthwashes: Antifungal and Antibiofilm Abilities of Commercially Available Mouthwashes Against Candida spp.Antibiotics (Basel)2025https://conductscience.org/library/papers/40426549PubMed
40135881Vesicle inhibition reduces Candida biofilm resistance.Antimicrob Agents Chemother2025https://conductscience.org/library/papers/40135881PubMed
39731595Exploring the anti-biofilm and gene regulatory effects of anti-inflammatory drugs on Candida albicans.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39731595PubMed
39576268The mechanism research of itraconazole combined with aspirin in the treatment of vulvovaginal candidiasis through NF-κB signaling pathway.Biomol Biomed2025https://conductscience.org/library/papers/39576268PubMed
38136707Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils.Antibiotics (Basel)2023https://conductscience.org/library/papers/38136707PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37589736

GET https://conductscience.org/api/papers/v1/37589736/references?page=2